Tratamiento de la enfermedad de Hodgkin: protocolo nacional de drogas antineoplásicas: informe preliminar / Treatment of Hodgkin's disease: National Protocol on Antineoplastic Drugs: preliminary report
Rev. méd. Chile
;
119(1): 11-21, ene. 1991. tab
Article
in Spanish
| LILACS
| ID: lil-98176
ABSTRACT
We report preliminary results of treatment of Hodgkin disease according to the National Protocol on Antineoplastic Drugs. 37 males and 22 females with a median age of 34 years (range 16 to 76) were treated. Patients with stages I or II received radiotherapy alone or chemotherapy (C-MOPP) followed by radiotherapy. Patients with stages III or IV received radiotherapy and chemotherapy or alternating courses of D-MOPP and ABVD. Complete remission was observed in 74% of 39 patients completing full therapy. Complete remission was more common in patients with nodular sclerosis without B symptoms and under 45 years of age. Actuarial survival at 22 months was 79%, significantly higher for patients with nodular sclerosis compared to patients with lymphocytic depletion. Different treatments in patients at stages I an II or III and IV gave comparable results. Complications included infection with the Chickenpox-Zoster virus, pneumonia and fever of Unknown origin. Mortality was associated to older age, complications of treatment or failure to comply with therapy
Search on Google
Index:
LILACS (Americas)
Main subject:
Hodgkin Disease
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Practice guideline
/
Prognostic study
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS